DISCOUNT OPTIONSSCHEIN - AMGEN | Delayed Börse Stuttgart 10:00:40 13/05/2024 BST | ||
| 5.54 EUR | -2.29% |
|
| Current month | +106.18% | ||
| 1 month | +106.93% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
More news
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/05/24 | 5.54 | -2.29% | 0 |
| 10/05/24 | 5.67 | -4.87% | 0 |
| 09/05/24 | 5.96 | +17.79% | 0 |
| 08/05/24 | 5.06 | +5.86% | 0 |
| 07/05/24 | 4.78 | -19.26% | 0 |
Delayed Quote Börse Stuttgart
Last update May 13, 2024 at 10:00 am
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | Morgan Stanley |
| WKN | ME66P4 |
| ISIN | DE000ME66P46 |
| Date issued | 02/01/2024 |
| Strike | 360 $ |
| Maturity | 20/12/2024 (221 Days) |
| Parity | 1 : 1 |
| Emission price | 2.83 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 8.03 € |
|---|---|
| Lowest since issue | 2.39 € |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
310.2
USD
Average target price
314.6
USD
Spread / Average Target
+1.45%
- Stock Market
- Certificates
- Certificat
